万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
1
- 英文名:
EpiQuik Histone Demethylase LSD1 Activity/Inhibition Assay Kit
- 保质期:
6个月
- 供应商:
上海再康
- 保存条件:
4℃保存
- 组蛋白去甲基酶LSD1活性/抑制分析试剂盒详细信息:
-
Product Overview
The EpiQuik™ Histone Demethylase LSD1 Activity/Inhibition Assay Kit is a convenient set of tools that allows the experimenter to measure activity/inhibition of LSD1. The kit is ready-to-use and provides all the essential components needed for measuring histone demethylase LSD1 activity/inhibition from a broad range of species including mammalian cells/tissues, plants, and bacteria.
WHY CHOOSE THE EPIQUIK™ HISTONE DEMETHYLASE LSD1 ACTIVITY/INHIBITION ASSAY KIT?
- Fast procedure, which can be finished within 3 hours.
- Innovative fluorescent assay with no use of radioactivity, extraction, and chromatography.
- Direct measurement of LSD1 activity and not interfered by thiol-containing chemicals such as DTT, GSH and 2-mercaptoethanol.
- Both of cell/tissue extracts and purified LSD1 can be used, which allows to detect inhibitory effect of LSD1 inhibitor in vivo and in vitro.
- Strip microplate format makes the assay flexible: manual or high throughput analysis.
- Simple, reliable, and consistent assay conditions.
组蛋白去甲基酶LSD1活性/抑制分析试剂盒Principle & Procedure
The EpiQuik™ Histone Demethylase LSD1 Activity/Inhibition Assay Kit is designed for measuring cellular LSD1 activity/inhibition. In the assay with this kit, the unique di-methylated histone H3-K4 substrate is stably captured on the strip wells. Active LSD1 bind to and demethylate histone H3-K4 substrate. The remaining un-demethylated substrate can be recognized with high affinity anti-methylated histone H3-K4 antibody. The ratio or amount of the un-demethylated histone, which is inversely proportional to LSD1activity, can then be fluorimetrically quantified.
SCHEMATIC PROCEDURE: 组蛋白去甲基酶LSD1活性/抑制分析试剂盒Product Components
HG1 (10x wash buffer)
HG2 (LSD1 assay buffer)
HG3 (LSD1 substrate)*
HG4 (LSD1 standard, 20 µg/ml)*
HG5 (capture antibody 100 µg/ml)*
HG6 (detection antibody 200 µg/ml)*
HG7 (fluoro-developer)
8 well assay strip (with frame)
User guide
zkB347Hu 垂体腺苷酸环化酶激活肽(ADCYAP1)ELISA试剂盒 检测范围
zkB348Hu 腺苷酸环化酶1(ADCY1)ELISA试剂盒 检测范围
zkB350Hu 脂肪分化相关蛋白(ADRP)ELISA试剂盒 检测范围
zkA323Hu 不均一核糖核蛋白A2/B1(HNRPA2B1)ELISA试剂盒 检测范围
zkB028Hu 抗白蛋白抗体(AAA)ELISA试剂盒 检测范围
zkA344Hu 回肠脂肪酸结合蛋白(FABP6)ELISA试剂盒 检测范围
zkA430Hu 沉默调节蛋白2(SIRT2)ELISA试剂盒 检测范围
zkA909Hu 铜蓝蛋白(CP)ELISA试剂盒 检测范围
zkA896Hu 半胱氨酸蛋白酶抑制剂3(CST3)ELISA试剂盒 检测范围
zkA899Hu 骨桥素(OPN)ELISA试剂盒 检测范围
zkA893Hu Ⅲ型胶原交联羧基端肽(CTXⅢ)ELISA试剂盒 检测范围
zkA892Hu β-骨胶原交联(βCTx)ELISA试剂盒 检测范围
zkA589Hu 血红素氧合酶2(HO2)ELISA试剂盒 检测范围
zkA382Hu 蛋白激酶Bγ(PKBγ)ELISA试剂盒 检测范围
zkA383Hu 磷酸肌醇-3-激酶2α肽(PI3K2α)ELISA试剂盒 检测范围
zkA831Hu 凝血酶/抗凝血酶复合体(TAT)ELISA试剂盒 检测范围
zkA832Hu 纤溶酶/抗纤溶酶复合体(PAP)ELISA试剂盒 检测范围
zkA833Hu 血管性血友病因子(vWF)ELISA试剂盒 检测范围
zkA834Hu 凝血因子Ⅹ(F10)ELISA试剂盒 检测范围
zkA840Hu 凝血因子Ⅸ(F9)ELISA试剂盒 检测范围
zkA842Hu 脂蛋白a(Lpa)ELISA试剂盒 检测范围
zkA810Hu 心肌营养素1(CT1)ELISA试剂盒 检测范围
zkA384Hu 白介素23(IL23)ELISA试剂盒 检测范围
zkA385Hu 白介素27(IL27)ELISA试剂盒 检测范围
zkA901Hu 多巴胺受体D3(DRD3)ELISA试剂盒 检测范围
zkA848Hu 糖原磷酸化酶M(PYGM)ELISA试剂盒 检测范围
zkA849Hu 糖原磷酸化酶L(PYGL)ELISA试剂盒 检测范围
zkA882Hu 胃泌素抑制肽(GIP)ELISA试剂盒 检测范围
zkA591Hu 抗增殖细胞核抗原(PCNA)ELISA试剂盒 检测范围
zkA593Hu 肌原纤蛋白1(FBN1)ELISA试剂盒 检测范围
zkA391Hu 卵泡抑素(FS)ELISA试剂盒 检测范围
zkA387Hu 补体3a(C3a)ELISA试剂盒 检测范围
zkA388Hu 补体成分5a(C5a)ELISA试剂盒 检测范围
* For maximum recovery of the products, centrifuge the original vial after thawing prior to opening the cap.组蛋白去甲基酶LSD1活性/抑制分析试剂盒User Guide & MSDS
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验。染色体中的组蛋白去乙酰化可使染色体的结构更加致密,从而抑制基因的转录。组蛋白去乙酰化酶抑制剂使染色体由致密状态变为活化状态,从而使一些抑制肿瘤生长的基因激活。因此,这些抑制剂有望开发为肿瘤治疗的药物。组蛋白去乙酰化酶(HDAC)在哺乳动物中可分为3类。 (1)第一类:为酵母转录调控子 RPD3 蛋白的同类物,这是第一个被鉴定出来的 HDAC。它包括 HDACl~3,可与转录因子E2F 结合,通过与 Rb 蛋白相关途径抑制转录。 (2)第二类:为酵母 HDAl 类蛋白质,包括 HDAC4~
在检测试剂盒的设计上。典型 HMT 检测试剂盒用 3H-SAM 作甲基供体,并将 S-腺苷高半胱氨 酸 (SAH) 测定为甲基化反应的一般副产物。但是,这需要 处理放射性物质 较高的灵敏度,以克服甲基供体 SAM 的低 kcat(转化数通常 预先纯化酶/蛋白复合物,以评估特定 HMTs 的活性 比色或荧光检测简便,无放射性 与核提取物或纯化蛋白的相容性(检测试剂盒对目标修饰具有特异性) 3 小时内即可提供数据 表征去甲基酶活性 组蛋白去甲基化酶活性检测试剂盒通常测定
断骨难愈合?中科院邹卫国等 Sci Adv 报道其中表观遗传学调控关键分子
骨发育不良、无肱骨三角肌隆起等等表型(图 2)。以上结果表明 LSD1 在骨骼修复和骨骼发育过程中调控 SOX9 的表达水平。3. LSD1 通过抑制 ALDH1A2 抑制维甲酸(RA)信号传导已有研究表明,LSD1 对其 H3K4me1 / 2 脱甲基酶活性起转录抑制作用,对其 H3K9 脱甲基酶活性起转录激活作用。由于 LSD1 的缺失不会改变 Sox9 启动子区域的 H3K9 甲基化水平,因此作者猜测 LSD1 可能通过其 H3K4me1 / 2 脱甲基酶活性来抑制调控 Sox9 表达的信号
技术资料暂无技术资料 索取技术资料






